Abstract
Proton radiotherapy offers the possibility of quality coverage of the target volumes, which reducing the dose absorbed by critical organs, especially in patients where these doses tend to be high. This concerns especially doses absorbed by the cardiac muscle, coronary arteries, lungs and the contralateral breast.
It is also necessary to define the sub-group of patients who will benefit the most from proton radiotherapy.